TAF
Tredje AP-fonden Portfolio holdings
AUM
$12.6B
This Quarter Return
+7.14%
1 Year Return
+20.01%
3 Year Return
+108.71%
5 Year Return
+188.48%
10 Year Return
+455.91%
AUM
$1.56B
AUM Growth
+$1.56B
(+52%)
Cap. Flow
+$466M
Cap. Flow
% of AUM
29.89%
Top 10 Holdings %
Top 10 Hldgs %
32.76%
Holding
314
New
16
Increased
247
Reduced
24
Closed
24
Top Buys
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
$159M |
| 2 |
iShares US Healthcare ETF
IYH
|
$126M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
$15.9M |
| 4 |
Johnson & Johnson
JNJ
|
$12.7M |
| 5 |
Viatris
VTRS
|
$11.1M |
Top Sells
| 1 |
Alphabet (Google) Class C
GOOG
|
$15.1M |
| 2 |
Apple
AAPL
|
$8.55M |
| 3 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$6.83M |
| 4 |
Duke Energy
DUK
|
$3.26M |
| 5 |
Dominion Energy
D
|
$2.68M |
Sector Composition
| 1 | Healthcare | 26.64% |
| 2 | Financials | 10.51% |
| 3 | Technology | 9.71% |
| 4 | Communication Services | 8.2% |
| 5 | Consumer Staples | 6.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
iShares MSCI Emerging Markets ETF
EEM
$19B
| $159M | 10.21% | +4,942,473 | New | +$159M |
|
|
2
iShares US Healthcare ETF
IYH
$2.75B
| $126M | 8.11% | +832,000 | New | +$126M |
|
|
3
Apple
AAPL
$3.45T
| $37.3M | 2.4% | 354,826 -81,185 | -19% | -$8.55M |
|
4
Pfizer
PFE
$141B
| $31.4M | 2.01% | 972,580 +215,631 | +28% | +$6.96M |
|
5
Amgen
AMGN
$155B
| $29.6M | 1.9% | 182,574 +33,504 | +22% | +$5.44M |
|
6
Gilead Sciences
GILD
$140B
| $28M | 1.8% | 276,806 +69,393 | +33% | +$7.02M |
|
7
AbbVie
ABBV
$372B
| $27.9M | 1.79% | 470,592 +11,754 | +3% | +$696K |
|
8
Microsoft
MSFT
$3.77T
| $27M | 1.73% | 486,333 +6,378 | +1% | +$354K |
|
|
CELG
9
DELISTED
Celgene Corp
CELG
| $22.6M | 1.45% | 188,542 +37,387 | +25% | +$4.48M |
|
10
Exxon Mobil
XOM
$487B
| $21.3M | 1.37% | 273,280 +3,685 | +1% | +$287K |
|
11
Amazon
AMZN
$2.44T
| $19.5M | 1.25% | 28,874 +1,366 | +5% | +$923K |
|
12
Merck
MRK
$210B
| $19.4M | 1.24% | 364,065 +179,522 | +97% | +$9.56M |
|
13
GE Aerospace
GE
$292B
| $19.3M | 1.24% | 615,732 -32,325 | -5% | -$1.01M |
|
|
14
Johnson & Johnson
JNJ
$427B
| $18.1M | 1.16% | 176,640 +123,460 | +232% | +$12.7M |
|
|
AGN
15
DELISTED
Allergan plc
AGN
| $17.8M | 1.14% | 57,071 +31,728 | +125% | +$9.92M |
|
16
Meta Platforms (Facebook)
META
$1.86T
| $17.7M | 1.14% | 169,588 +622 | +0.4% | +$65.1K |
|
17
Bristol-Myers Squibb
BMY
$96B
| $17.5M | 1.13% | 253,489 +145,545 | +135% | +$10.1M |
|
18
Wells Fargo
WFC
$263B
| $17.3M | 1.11% | 318,680 +4,499 | +1% | +$245K |
|
|
19
Alphabet (Google) Class C
GOOG
$2.58T
| $17.1M | 1.1% | 22,559 -19,938 | -47% | -$15.1M |
|
|
20
Alphabet (Google) Class A
GOOGL
$2.57T
| $15.9M | 1.02% | +20,496 | New | +$15.9M |
|
21
JPMorgan Chase
JPM
$829B
| $15.9M | 1.02% | 240,259 +3,548 | +1% | +$234K |
|
22
Home Depot
HD
$405B
| $14.6M | 0.93% | 110,094 -2,248 | -2% | -$297K |
|
23
Biogen
BIIB
$19.4B
| $14.2M | 0.91% | 46,345 +31,193 | +206% | +$9.56M |
|
24
Procter & Gamble
PG
$368B
| $14.1M | 0.9% | 177,587 +2,387 | +1% | +$190K |
|
25
Eli Lilly
LLY
$657B
| $14.1M | 0.9% | 166,824 +103,537 | +164% | +$8.72M |
|